The oxidative modification hypothesis of atherosclerosis: Does it hold for humans?

Trends in Cardiovascular Medicine

Volumn 11, Issue 3-4, 2001, Pages 93-102

  Witztum, Joseph L ^a,b   Steinberg, Daniel ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BUTYLCRESOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN; N,N' DIPHENYL 1,4 PHENYLENEDIAMINE; OMEGA 3 FATTY ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; RAMIPRIL;

ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DATA ANALYSIS; EXPERIMENTAL MODEL; GENETIC MANIPULATION; HEART INFARCTION PREVENTION; HUMAN; HYPOTHESIS; IN VIVO STUDY; INHIBITION KINETICS; LIPID OXIDATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; CHOLESTEROL; CLINICAL TRIALS; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; OXIDATIVE STRESS; REVIEW LITERATURE;

EID: 0035176943     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(01)00111-6     Document Type: Review

References (103)

1. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
2. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase
3. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice
4. Removal of cholesterol from extrahepatic sources by oxidative mechanisms
5. The antioxidant butylated hydroxytoluene protects against atherosclerosis
6. Oxidative stress and cardiovascular disease in hemodialysis
7. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
8. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit
9. An animal model to study local oxidation of LDL and its biological effects in the arterial wall
10. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
11. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition
12. The oxidative modification hypothesis of atherogenesis: An overview
13. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse
14. Antiatherogenic effects of the antioxidant BO-653 in three different animal models
15. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E deficient mice
16. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
17. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits
18. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits
19. Vitamin C intake and mortality among a sample of the United States population
20. Biochemical, structural, functional properties of oxidized low-density lipoprotein
21. Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase
22. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
23. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques
24. Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits
25. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits
26. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation
27. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
28. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice
29. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
30. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture
31. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
32. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
33. Lipoprotein oxidation and lipoprotein-induced cytotoxicity
34. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease
35. Immunological responses to oxidized LDL
36. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
37. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages
38. Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits
39. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody
40. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: Effect of vitamin E supplementation
41. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data
42. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
43. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits
44. In vivo action of 15-lipoxygenase in early stages of human atherogenesis
45. Atherogenesis and inflammation
46. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis
47. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits
48. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol
49. Effects of vitamin E on lipid peroxidation in healthy persons
50. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides
51. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis
52. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture
53. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein
54. Hypercholesterolemia increases endothelial superoxide anion production
55. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
56. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma
57. Low density lipoprotein undergoes oxidative modification in vivo
58. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis
59. Relation of vascular oxidative stress, alpha-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters
60. Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E
61. Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: Effects of probucol
62. Localization of distinct F2-isoprostanes in human atherosclerotic lesions
63. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
64. Evidence for a dominant role of lipoxygenases in the oxidation of LDL by mouse peritoneal macrophages
65. Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM
66. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene
67. Increased formation of distinct F2 isoprostanes in hypercholesterolemia
68. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene
69. Vitamin E consumption and the risk of coronary heart disease in men
70. Atherosclerosis: An inflammatory disease
71. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
72. Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties
73. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations
74. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits
75. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
76. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine
77. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification
78. Vitamin E consumption and the risk of coronary disease in women
79. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels
80. Antioxidants in the prevention of human atherosclerosis
81. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?
82. Preventing coronary artery disease by lowering cholesterol levels: Fifty years from bench to bedside
83. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
84. Lipoproteins and atherogenesis. Current concepts
85. Lipoproteins, lipoprotein oxidation, and atherogenesis
86. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
87. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
88. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
89. Effect of the antioxidant N,N′-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice
90. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice
91. The oxidative modification hypothesis of atherogenesis
92. Effects of d-a-tocopherol supplementation on experimentally induced primate atherosclerosis
93. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits
94. Site-specific antiatherogenic effect of probucol in apolipoprotein E-deficient mice
95. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice
96. The oxidation hypothesis of atherosclerosis
97. To E or not to E: How do we tell?
98. Is oxidized low-density lipoprotein present in vivo?
99. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL
100. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
101. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions
102. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
103. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice